Phenytoin and its metabolite, 5-(4-hydroxyphenyl)-5-phenylhydantoin, show bone resorption in cultured neonatal mouse calvaria
Citation
A. Takahashi et al., Phenytoin and its metabolite, 5-(4-hydroxyphenyl)-5-phenylhydantoin, show bone resorption in cultured neonatal mouse calvaria, JPN J PHARM, 82(1), 2000, pp. 82-84
Categorie Soggetti
Pharmacology & Toxicology
Journal title
JAPANESE JOURNAL OF PHARMACOLOGY
SICI code
0021-5198(200001)82:1<82:PAIM5S>2.0.ZU;2-X
Abstract
The effects of phenytoin and its major metabolite, 5-(4-hydroxyphenyl)-5-ph
enylhydantoin (HPPH), on bone resorption of neonatal mouse calvaria were ex
amined in vitro. Both phenytoin and HPPH induced significant bone resorptio
n as compared to the controls after 72 h in culture. This effect may be the
cause of phenytoin-induced bone loss in vivo.